Probucol reduces the rate of association of apolipoprotein C-III with dimyristoylphosphatidylcholine

This publication has 29 references indexed in Scilit:

• Long-term use of probucol in the multifactorial primary prevention of vascular disease
  The American Journal of Cardiology, 1986
• Effect of probucol treatment on lipoprotein cholesterol and drug levels in blood and lipoproteins in familial hypercholesterolemia
  Atherosclerosis, 1985
• The hypolipidemic action of probucol
  Atherosclerosis, 1985
• The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia
  Atherosclerosis, 1982
• Kinetics of lipid-protein interactions: effect of cholesterol on the association of human plasma high-density apolipoprotein A-I with L-.alpha.-dimyristoylphosphatidylcholine
  Biochemistry, 1979
• Interaction of plasma high density lipoprotein HDL_2b (d 1.063–1.100 g/ml) with single‐bilayer liposomes of dimyristoylphosphatidylcholine
  Lipids, 1978
• Kinetics of lipid-protein interactions: interaction of apolipoprotein A-I from human plasma high density lipoproteins with phosphatidylcholines
  Biochemistry, 1978
• Physical properties of the dimyristoylphosphatidylcholine vesicle and of complexes formed by its interaction with apolipoprotein C-III
  Biochemistry, 1977
• Solubilisation of phospholipid membranes by human plasma high density lipoproteins
  Nature, 1977
• Lipoprotein Metabolism1 1In preparation of this study, Dr. Eisenberg was supported in part through the Special Foreign Currency Program of the National Library of Medicine, National Institutes of Health, Public Health Service, U. S. Department of Health, Education, and Welfare, Bethesda, Maryland, under an agreement with the Israel Journal of Medical Sciences, Jerusalem, Israel.
  Published by Elsevier ,1975